Security Snapshot

PRECIGEN, INC. - Common Stock (PGEN) Institutional Ownership

CUSIP: 74017N105

13F Institutional Holders and Ownership History from Q1 2016 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

204

Shares (Excl. Options)

133,615,849

Price

$3.87

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-3,533,269
Value change
-$15,166,461
Number of holders
204
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
353,007,843
SEC-reported price per share
$4.51
Insider filing price
$4.51
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • PGEN - PRECIGEN, INC. - Common Stock is tracked under CUSIP 74017N105.
  • 204 institutions reported positions in Q1 2026.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 179 to 204 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $568,542,925 to $516,611,810.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 204 institutions filings for Q1 2026.

Open SEC evidence

Security key

74017N105

Latest holder period

Q1 2026

13F holders

204

13D/G owners

3

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
PGEN
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Patient Capital Management, LLC 10% -24% $150,508,424 -$38,525,651 36,006,800 -20% Patient Capital Management, LLC 31 Dec 2025
Miller William H III 9.2% $154,936,259 34,051,925 William H. Miller III Living Trust dated April 17, 2017 26 Jun 2025
Point72 Asset Management, L.P. 5.2% $76,841,952 18,383,242 Point72 Asset Management, L.P. 22 Jan 2026

As of 31 Mar 2026, 204 institutional investors reported holding 133,615,849 shares of PRECIGEN, INC. - Common Stock (PGEN). This represents 38% of the company’s total 353,007,843 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
32%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Patient Capital Management, LLC 5% 17,817,387 -4.6% 2.6% $68,953,288
BlackRock, Inc. 4.3% 15,223,191 +0.85% 0% $58,913,751
STATE STREET CORP 3.1% 10,890,124 +0.6% 0% $42,144,780
VANGUARD CAPITAL MANAGEMENT LLC 2% 7,148,996 0% 0% $27,666,615
Diametric Capital, LP 1.9% 6,801,788 +77% 6.9% $26,322,919
Point72 Asset Management, L.P. 1.9% 6,644,361 -52% 0.04% $25,713,677
TANG CAPITAL MANAGEMENT LLC 1.8% 6,417,500 +14% 1.3% $24,835,725
GEODE CAPITAL MANAGEMENT, LLC 1.3% 4,613,429 +3.4% 0% $17,856,721
Occam Crest Management LP 1.2% 4,269,051 +22% 10% $16,521,227
IRIDIAN ASSET MANAGEMENT LLC/CT 1% 3,592,730 -0.21% 5.6% $13,903,865
Boxer Capital Management, LLC 0.99% 3,500,000 +155% 1.8% $13,545,000
GOLDMAN SACHS GROUP INC 0.95% 3,350,477 +54% 0% $12,966,346
CITADEL ADVISORS LLC 0.77% 2,702,383 -17% 0.01% $10,458,222
FRANKLIN RESOURCES INC 0.75% 2,633,780 +463% 0% $10,192,728
MORGAN STANLEY 0.68% 2,414,322 -24% 0% $9,343,427
VANGUARD PORTFOLIO MANAGEMENT LLC 0.6% 2,116,011 0% 0% $8,188,963
FMR LLC 0.57% 1,998,596 -57% 0% $7,734,566
JANE STREET GROUP, LLC 0.52% 1,821,790 0.01% $7,050,327
NORTHERN TRUST CORP 0.46% 1,611,790 +2.1% 0% $6,237,627
BANK OF AMERICA CORP /DE/ 0.42% 1,471,279 -33% 0% $5,693,849
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.41% 1,460,620 -3.1% 0% $5,652,599
Woodline Partners LP 0.4% 1,401,412 +0.03% 0.02% $5,423,464
PRELUDE CAPITAL MANAGEMENT, LLC 0.36% 1,270,053 +95% 0.38% $4,915,105
VANGUARD FIDUCIARY TRUST CO 0.34% 1,197,703 0% 0% $4,635,111
Corient Private Wealth LLC 0.26% 911,206 +111% 0.01% $3,526,368

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
31
Latest
Q1 2026
Rows shown
1-25 of 31
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 133,615,849 $516,611,810 -$15,166,461 $3.87 204
2025 Q4 136,011,489 $568,542,925 +$96,374,703 $4.18 179
2025 Q3 111,297,177 $366,220,521 +$89,540,533 $3.29 165
2025 Q2 82,070,744 $116,553,437 +$2,653,090 $1.42 146
2025 Q1 80,161,429 $119,337,253 +$7,804,799 $1.49 137
2024 Q4 75,787,342 $84,752,627 +$1,018,038 $1.12 130
2024 Q3 74,934,960 $70,966,781 +$13,973,301 $0.95 123
2024 Q2 60,722,436 $95,930,395 -$1,354,697 $1.58 130
2024 Q1 61,605,921 $89,315,893 -$1,244,521 $1.45 127
2023 Q4 62,597,104 $83,879,140 +$2,482,228 $1.34 136
2023 Q3 60,552,257 $85,976,957 +$4,927,378 $1.42 135
2023 Q2 57,391,361 $65,981,492 -$3,631,686 $1.15 137
2023 Q1 61,459,047 $65,137,179 +$19,788,601 $1.06 155
2022 Q4 42,284,714 $64,263,385 -$330,510 $1.52 157
2022 Q3 125,018,911 $265,021,859 -$18,455,826 $2.12 151
2022 Q2 135,952,580 $182,176,824 -$10,848,844 $1.34 154
2022 Q1 143,469,817 $302,712,530 +$212,819 $2.11 159
2021 Q4 142,860,197 $529,867,886 +$12,686,695 $3.71 157
2021 Q3 138,272,261 $690,254,065 -$19,066,872 $4.99 162
2021 Q2 142,052,644 $926,165,482 -$505,170 $6.52 142
2021 Q1 142,033,611 $978,581,859 +$140,930,422 $6.89 154
2020 Q4 121,129,113 $1,235,480,007 -$19,579,424 $10.20 142
2020 Q3 123,718,445 $433,031,361 +$6,466,151 $3.50 145
2020 Q2 121,163,398 $604,513,971 -$28,168,416 $4.99 134
2020 Q1 129,153,759 $439,106,078 +$437,977,926 $3.40 134
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .